green tick

Sigma share price slumps after announcement

0 comments Read Later

Sigma share price slumps after announcement

Sigma’s share price has slumped in response to an ASX announcement that its 2018 profit will be lower than forecast.

Sigma expects earnings before interest and tax (EBIT) of $90 million for the next fiscal year, below the current market consensus of around $95 million.

By mid-afternoon on Friday the share price had dropped by 6% to just over 87 cents.

The company blames the earning pressure on “general market conditions” and its ongoing focus on “enforcing consistent brand standards to improve brand performance”.

It says it has taken steps to improve sales and grow market share and “provide momentum” into 2019.

CEO Mark Hooper says the company is confident its strategy and increased investment in infrastructure will deliver growth and efficiencies beyond 2017.

Earlier this month a rival, Australian Pharmaceutical Industries (API), downgraded its profit forecast as a result of declining customer spending.

API, which owns Priceline, said customers were spending less per basket and buying cheaper items.


 

 Subscribe to our Newsletter


 Breaking news and special features
 A daily must-read for pharmacists
 Delivered to your inbox
By filling in your email address and clicking submit with this option selected, you agree to receive email communications from us relevant to the healthcare industry. You always have the option of unsubscribing later via an unsubscribe link or your subscriptions management page. View our privacy policy here.

Your profile is
0% complete


 
 

Pharmacy News on Twitter

­

My list
  •  
Read Later